Analyst Ratings For Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Today, Maxim Group set its price target on Adial Pharmaceuticals Inc (NASDAQ:ADIL) to $5.00 per share.
There are 2 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Adial Pharmaceuticals Inc (NASDAQ:ADIL) is Buy with a consensus target price of $5.00 per share, a potential 48.81% upside.
Some recent analyst ratings include
- 10/11/2018-Adial Pharmaceuticals Inc (NASDAQ:ADIL) has coverage initiated with a Buy rating
Recent Trading Activity for Adial Pharmaceuticals Inc (NASDAQ:ADIL)
Shares of Adial Pharmaceuticals Inc closed the previous trading session at 3.36 up +1.33 65.52% with 3.99 shares trading hands.
